Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
PatSnap Eureka Desktop
NEWAnalytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Telecom SEP Claim Chart
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport PAN accounts for 90%+ of carbon fiber production but 50% of its cost. Explore the 2026 patent landscape for PAN, pitch, and lignin-based CFRP precursor routes.
Article | Rapport How MPC of active front-end rectifiers achieves superior power factor correction and THD reduction in industrial drives — evidence from 50+ peer-reviewed studies.
Article | Rapport PEDOT:PSS, polyaniline, and polypyrrole in flexible electronics and sensors: engineering strategies, performance data, and IP landscape for 2026.
Article | Rapport PD-1/PD-L1 inhibitors, somatostatin analogs, and mTOR-targeted agents in thymoma and thymic carcinoma: clinical evidence, molecular targets, and pipeline signals.
Article | Rapport How to reduce common-mode leakage current in transformerless PV inverters to meet IEC 62109. Topology, modulation, and control strategies reviewed.
Article | Rapport Explore the neonatal RDS drug pipeline: synthetic surfactant evolution, inhaled nitric oxide for PPHN, and novel PPARγ, exosome, and antioxidant lung maturation strategies.
Article | Rapport How phasor measurement units enable early detection of inter-area oscillations in large power grids — signal processing, source localization, and damping control.
Article | Rapport PEDOT:PSS, polyaniline, and polypyrrole in flexible electronics and sensors: engineering strategies, key players, and IP trends for 2026. 50+ sources analysed.
Article | Rapport Anti-VEGF intravitreal dosing, IGF-1 signalling, and laser adjunct approaches in the ROP drug pipeline — evidence from 1,627-eye cohorts and emerging targets.
Article | Rapport How to reduce flicker noise from grid-tied inverters in weak grid conditions: control strategies, impedance reshaping, PLL redesign, and filter techniques explained.
Article | Rapport MSC therapy, IGF-1, and TGF-β antagonism are reshaping the BPD drug pipeline. Explore the clinical evidence, patent landscape, and emerging regenerative strategies.
Article | Rapport How DERMS and predictive grid edge control reduce solar curtailment in high-PV networks — OPF, MPC, smart inverters and real-world validation from NREL, EPFL and more.
Article | Rapport Explore the RPL drug pipeline: LMWH, IVIg, tacrolimus, PRP, and hydroxychloroquine targeting thrombophilia, immune dysregulation, and uterine receptivity.
Article | Rapport How to reduce capacity loss from transition metal dissolution in high-voltage spinel cathodes: electrolyte engineering, crystal facet control, and single-crystal design.
Article | Rapport Explore the female infertility drug pipeline: FSH analogs, AMH biomarkers, kisspeptin triggers, and ovarian stimulation protocols shaping the next wave of fertility treatments.